Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 120.45% is 65% below its 4-year average of 340.10%, near the low end of its 4-year range (-74.17%–1734.41%).
As of the fiscal period ended Wednesday, December 31, 2025. 87.01% below its 12-month average of 927.43%.
Annual fiscal-year return on equity; no daily interpolation. Historical series through 2025-12-31.
RETURN ON EQUITY (ROE)
120.45%
RETURN ON EQUITY (ROE) AVG TTM
927.43%
RETURN ON EQUITY (ROE) AVG 3Y
433.61%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-87.01%
CURRENT VS 3Y AVG
-72.22%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 651 covered companies
CURRENT VS SECTOR MEDIAN
+399.63%
vs the sector median at left
MBody AI Ltd.
Market Cap
$3.17M
Return on Equity (ROE)
120.45%
TTM Avg
927.43%
3Y Avg
433.61%
5Y Avg
N/A
Market Cap
$3.20M
Return on Equity (ROE)
-141.90%
TTM Avg
-194.17%
3Y Avg
-143.89%
5Y Avg
-113.05%
Market Cap
$3.12M
Return on Equity (ROE)
-106.79%
TTM Avg
-210.00%
3Y Avg
-362.69%
5Y Avg
1766.26%
Market Cap
$3.25M
Return on Equity (ROE)
-40.75%
TTM Avg
-35.89%
3Y Avg
-218.64%
5Y Avg
-156.11%
Market Cap
$3.07M
Return on Equity (ROE)
-365.43%
TTM Avg
-2048.73%
3Y Avg
-1082.52%
5Y Avg
-614.77%
Market Cap
$3.29M
Return on Equity (ROE)
-133.43%
TTM Avg
-203.84%
3Y Avg
-174.81%
5Y Avg
-140.61%
Market Cap
$2.99M
Return on Equity (ROE)
N/A
TTM Avg
-236.13%
3Y Avg
-104.67%
5Y Avg
-48.54%
Market Cap
$3.34M
Return on Equity (ROE)
-282.13%
TTM Avg
-313.25%
3Y Avg
-153.55%
5Y Avg
-153.55%
Market Cap
$3.37M
Return on Equity (ROE)
-89.85%
TTM Avg
30.83%
3Y Avg
-183.24%
5Y Avg
-146.59%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBody AI Ltd. (MBAI) | $3.17M | 120.45% | 927.43% | 433.61% | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.20M | -141.90% | -194.17% | -143.89% | -113.05% |
| Revelation Biosciences, Inc. (REVB)vs › | $3.12M | -106.79% | -210.00% | -362.69% | 1766.26% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -40.75% | -35.89% | -218.64% | -156.11% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | -365.43% | -2048.73% | -1082.52% | -614.77% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | -133.43% | -203.84% | -174.81% | -140.61% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.99M | N/A | -236.13% | -104.67% | -48.54% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.34M | -282.13% | -313.25% | -153.55% | -153.55% |
| Moolec Science S.A. (MLEC)vs › | $3.37M | -89.85% | 30.83% | -183.24% | -146.59% |
| Eocene Ltd. (EOCN)vs › | $3.46M | N/A | N/A | N/A | N/A |
ROE
120.5%
ROA
55.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 120.45% |
| 2024-12-31 | 1734.41% |
| 2023-12-31 | -74.17% |
| 2022-12-31 | -46.25% |
| 2021-12-31 | -33.94% |
